BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 25575575)

  • 1. Ga-68 MAA Perfusion 4D-PET/CT Scanning Allows for Functional Lung Avoidance Using Conformal Radiation Therapy Planning.
    Siva S; Devereux T; Ball DL; MacManus MP; Hardcastle N; Kron T; Bressel M; Foroudi F; Plumridge N; Steinfort D; Shaw M; Callahan J; Hicks RJ; Hofman MS
    Technol Cancer Res Treat; 2016 Feb; 15(1):114-21. PubMed ID: 25575575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-resolution pulmonary ventilation and perfusion PET/CT allows for functionally adapted intensity modulated radiotherapy in lung cancer.
    Siva S; Thomas R; Callahan J; Hardcastle N; Pham D; Kron T; Hicks RJ; MacManus MP; Ball DL; Hofman MS
    Radiother Oncol; 2015 May; 115(2):157-62. PubMed ID: 25935743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late-Course Adaptive Adjustment Based on Metabolic Tumor Volume Changes during Radiotherapy May Reduce Radiation Toxicity in Patients with Non-Small Cell Lung Cancer.
    Xiao L; Liu N; Zhang G; Zhang H; Gao S; Fu Z; Wang S; Yu Q; Yu J; Yuan S
    PLoS One; 2017; 12(1):e0170901. PubMed ID: 28125698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer.
    Bradley J; Thorstad WL; Mutic S; Miller TR; Dehdashti F; Siegel BA; Bosch W; Bertrand RJ
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):78-86. PubMed ID: 15093902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ventilation/Perfusion Positron Emission Tomography--Based Assessment of Radiation Injury to Lung.
    Siva S; Hardcastle N; Kron T; Bressel M; Callahan J; MacManus MP; Shaw M; Plumridge N; Hicks RJ; Steinfort D; Ball DL; Hofman MS
    Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):408-17. PubMed ID: 26275510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: a modeling study.
    van Der Wel A; Nijsten S; Hochstenbag M; Lamers R; Boersma L; Wanders R; Lutgens L; Zimny M; Bentzen SM; Wouters B; Lambin P; De Ruysscher D
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):649-55. PubMed ID: 15708242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical implications of defining the gross tumor volume with combination of CT and 18FDG-positron emission tomography in non-small-cell lung cancer.
    Grills IS; Yan D; Black QC; Wong CY; Martinez AA; Kestin LL
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):709-19. PubMed ID: 17197120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Impact of PET/CT on precise radiotherapy planning for non-small cell lung cancer].
    Gong HY; Yu JM; Fu Z; Li BS; Li JB; Liu TH
    Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):54-7. PubMed ID: 16737623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A potential to reduce pulmonary toxicity: the use of perfusion SPECT with IMRT for functional lung avoidance in radiotherapy of non-small cell lung cancer.
    Lavrenkov K; Christian JA; Partridge M; Niotsikou E; Cook G; Parker M; Bedford JL; Brada M
    Radiother Oncol; 2007 May; 83(2):156-62. PubMed ID: 17493699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of Functional Lung Heterogeneity and Dosimetry to Radiation Pneumonitis using Perfusion SPECT/CT and FDG PET/CT Imaging.
    Lee HJ; Zeng J; Vesselle HJ; Patel SA; Rengan R; Bowen SR
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1255-1264. PubMed ID: 30108002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional lung avoidance and response-adaptive escalation (FLARE) RT: Multimodality plan dosimetry of a precision radiation oncology strategy.
    Lee E; Zeng J; Miyaoka RS; Saini J; Kinahan PE; Sandison GA; Wong T; Vesselle HJ; Rengan R; Bowen SR
    Med Phys; 2017 Jul; 44(7):3418-3429. PubMed ID: 28453861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer.
    Ashamalla H; Rafla S; Parikh K; Mokhtar B; Goswami G; Kambam S; Abdel-Dayem H; Guirguis A; Ross P; Evola A
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1016-23. PubMed ID: 15979817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial assessment of FDG-PET FDG uptake and functional volume during radiotherapy (RT) in patients with non-small cell lung cancer (NSCLC).
    Edet-Sanson A; Dubray B; Doyeux K; Back A; Hapdey S; Modzelewski R; Bohn P; Gardin I; Vera P
    Radiother Oncol; 2012 Feb; 102(2):251-7. PubMed ID: 21885145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additional PET/CT in week 5-6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning?
    Gillham C; Zips D; Pönisch F; Evers C; Enghardt W; Abolmaali N; Zöphel K; Appold S; Hölscher T; Steinbach J; Kotzerke J; Herrmann T; Baumann M
    Radiother Oncol; 2008 Sep; 88(3):335-41. PubMed ID: 18514339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional lung volume mapping with perfusion Single-Photon Emission Computed Tomography scan for radiotherapy planning in patients with locally advanced nonsmall cell lung cancer.
    Follacchio GA; D'Urso P; Cassese R; Ferrara C; Bulzonetti N; Monteleone F; Musio D; Liberatore M; Tombolini V
    Nucl Med Commun; 2020 Oct; 41(10):1026-1033. PubMed ID: 32732597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.
    Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1432-41. PubMed ID: 16125870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy and Utility of Deformable Image Registration in (68)Ga 4D PET/CT Assessment of Pulmonary Perfusion Changes During and After Lung Radiation Therapy.
    Hardcastle N; Hofman MS; Hicks RJ; Callahan J; Kron T; MacManus MP; Ball DL; Jackson P; Siva S
    Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):196-204. PubMed ID: 26279034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A little to a lot or a lot to a little? An analysis of pneumonitis risk from dose-volume histogram parameters of the lung in patients with lung cancer treated with 3-D conformal radiotherapy.
    Willner J; Jost A; Baier K; Flentje M
    Strahlenther Onkol; 2003 Aug; 179(8):548-56. PubMed ID: 14509954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical utility of 4D FDG-PET/CT scans in radiation treatment planning.
    Aristophanous M; Berbeco RI; Killoran JH; Yap JT; Sher DJ; Allen AM; Larson E; Chen AB
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e99-105. PubMed ID: 21377285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mid-treatment adaptive planning during thoracic radiation using 68 Ventilation-Perfusion Positron emission tomography.
    Bucknell N; Hardcastle N; Gunewardena R; Nguyen L; Callahan J; Ball D; Selbie L; Kron T; Turgeon GA; Hofman MS; Siva S
    Clin Transl Radiat Oncol; 2023 May; 40():100599. PubMed ID: 36879654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.